Swiss Helvetia Fund
Swiss Helvetia Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through
Business Model:
Revenue: $28.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Swiss Helvetia Fund Information
Geographic Data
Address: 1270 Avenue of the Americas
City: New York
State: NY
Zip: 10020
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Swiss Helvetia Fund is a non-diversified, closed-end investment company whose objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The Fund also may acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
Contact Phone:
+12128677660
Contact Email:
Swiss Helvetia Fund went public on 8/28/1987 on the NYSE
Listed Exchange:
NYSE
IPO Date:
8/28/1987
Ticker Symbol:
SWZ
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2015 | Kuros Biosciences | Post-IPO Equity | 15.3M |
| 1/2009 | Synosia Therapeutics | Series B | 0 |
| 1/2012 | Selfrag | Series C | 9.6M |
| 10/2010 | Synosia Therapeutics | Series C | 0 |
| 8/2015 | Kuros Biosciences | Post-IPO Equity | 0 |
| 1/2012 | Selfrag | Series C | 0 |
| 10/2010 | Synosia Therapeutics | Series C | 0 |
| 1/2009 | Synosia Therapeutics | Series B | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
